Brijker F, Magee C C, Tervaert J W, O'Neill S, Walshe J J
Department of Clinical Immunology, University Hospital of Groningen, The Netherlands.
Clin Nephrol. 1999 Dec;52(6):344-51.
Objective scoring systems of disease activity and disease-associated damage have proven useful in the management of patients with systemic vasculitis.
We used the recently designed Birmingham vasculitis activity score (BVAS; maximum score 63) and vasculitis damage index (VDI; maximum score 59) to assess initial activity and long-term damage, respectively, in ANCA positive patients from one center over a 3-year period. Thirty-two patients with ANCA vasculitis were identified and analyzed as an historic cohort. The median BVAS for all vasculitis patients at first presentation was 19 (range 6 - 36). Patients with Wegener's granulomatosis had a significantly higher total score and respiratory BVAS score compared to the 15 with microscopic polyangiitis. The majority of patients received standard cyclophosphamide/steroid treatment.
At the end of follow-up (mean 24.9 months), 4 patients had died; all patients had evidence of permanent organ damage. The median total VDI score at last follow-up was 4.0 (range 0-11), with no differences between patients with Wegener's granulomatosis and microscopic polyangiitis. The VDI was not associated with the number of relapses. A high initial BVAS was found to correlate with a later high vasculitis damage index (r = 0.56). Initial renal or respiratory involvement was also associated with longterm damage in the same organ system.
Although mortality from ANCA-associated vasculitis has decreased, morbidity remains a common problem. High early-disease activity may identify patients at high risk of long-term organ damage, allowing more effective individualized therapy. This hypothesis requires validation in a prospective, controlled study.
疾病活动度和疾病相关损伤的客观评分系统已被证明在系统性血管炎患者的管理中有用。
我们使用最近设计的伯明翰血管炎活动评分(BVAS;最高评分63分)和血管炎损伤指数(VDI;最高评分59分),分别评估来自一个中心的ANCA阳性患者在3年期间的初始活动度和长期损伤。确定并分析了32例ANCA血管炎患者作为历史队列。所有血管炎患者首次就诊时的BVAS中位数为19(范围6 - 36)。与15例显微镜下多血管炎患者相比,韦格纳肉芽肿患者的总分和呼吸BVAS评分显著更高。大多数患者接受了标准的环磷酰胺/类固醇治疗。
随访结束时(平均24.9个月),4例患者死亡;所有患者均有永久性器官损伤的证据。最后一次随访时VDI总分中位数为4.0(范围0 - 11),韦格纳肉芽肿患者和显微镜下多血管炎患者之间无差异。VDI与复发次数无关。发现初始BVAS高与后期血管炎损伤指数高相关(r = 0.56)。初始肾脏或呼吸系统受累也与同一器官系统的长期损伤相关。
尽管ANCA相关血管炎的死亡率有所下降,但发病率仍然是一个常见问题。疾病早期活动度高可能识别出长期器官损伤风险高的患者,从而实现更有效的个体化治疗。这一假设需要在前瞻性对照研究中得到验证。